logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Edema

    FiltersReset Filters
    64 results
    • acetazolamide

      (Acetazolamide)
      Ajanta Pharma USA Inc.
      Usage: Acetazolamide is indicated as an adjunctive treatment for edema related to congestive heart failure and drug use, various forms of epilepsy, chronic and secondary glaucoma, and to lower intraocular pressure preoperatively in acute angle-closure glaucoma. It also prevents or alleviates symptoms of acute mountain sickness.
    • aldactone

      (spironolactone)
      Pfizer Laboratories Div Pfizer Inc
      Usage: ALDACTONE is indicated for treating NYHA Class III-IV heart failure, hypertension, edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It helps increase survival, manage edema, lower blood pressure, and provide preoperative or maintenance therapy for hyperaldosteronism cases.
    • bumetanide

      (Bumetanide)
      GLENMARK PHARMACEUTICALS INC., USA
      Usage: Bumetanide Injection is indicated for treating edema related to congestive heart failure, hepatic, and renal diseases, including nephrotic syndrome. It can be administered intravenously or intramuscularly when oral use is not feasible. It may be effective for patients who have had allergic reactions to furosemide.
    • bumetanide

      (Bumetanide)
      Edenbridge Pharmaceuticals LLC.
      Usage: Bumetanide tablets are indicated for treating edema associated with congestive heart failure, hepatic and renal diseases, including nephrotic syndrome. It can be administered orally or by intramuscular/intravenous routes if gastrointestinal absorption is impaired. It may be used in patients with allergic reactions to furosemide.
    • bumetanide

      (Bumetanide)
      Lupin Pharmaceuticals, Inc.
      Usage: Bumetanide injection is indicated for treating edema related to congestive heart failure, hepatic disease, renal disease, and nephrotic syndrome. It can be administered intramuscularly or intravenously when oral ingestion is impractical. It may also be used in patients with allergic reactions to furosemide, showing no cross-sensitivity.
    • bumetanide

      (bumetanide)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Bumetanide tablets are indicated for treating edema related to congestive heart failure, hepatic, and renal diseases, including nephrotic syndrome. If oral administration is impractical, it can be given intramuscularly or intravenously. It is effective even in patients with allergies to furosemide, showing no cross-sensitivity.
    • bumetanide

      (Bumetanide)
      Mullan Pharmaceutical Inc.
      Usage: Bumetanide Injection, USP is indicated for treating edema related to congestive heart failure, hepatic, and renal diseases, including nephrotic syndrome. It can be administered intramuscularly or intravenously when oral intake is not feasible or absorption is impaired. It may be suitable for patients allergic to furosemide.
    • bumetanide

      (bumetanide)
      Athenex Pharmaceutical Division, LLC.
      Usage: Bumetanide injection is indicated for treating edema related to congestive heart failure, hepatic disease, renal disease, and nephrotic syndrome. It can be administered orally or via injection if oral use is not feasible. It is effective even in patients with allergies to furosemide, showing no cross-sensitivity.
    • bumetanide

      (bumetanide)
      Zydus Lifesciences Limited
      Usage: Bumetanide tablets are indicated for treating edema related to congestive heart failure, hepatic and renal disease, including nephrotic syndrome. They can be administered orally or parenterally. Successful use in patients allergic to furosemide indicates a lack of cross-sensitivity.
    • bumetanide

      (Bumetanide)
      Gland Pharma Limited
      Usage: Bumetanide Injection is indicated for treating edema related to congestive heart failure, hepatic, and renal diseases, including nephrotic syndrome. It can be administered intramuscularly or intravenously when oral use is impractical or absorption is impaired. There is no significant cross-sensitivity with furosemide.
    • ...